Filing search / Incannex Healthcare Limited / "Healthcare" / Page 8

6-K

fi4 oq2mqx4kv

10 Aug 23

Report of Foreign Private Issuer

6:03am

6-K

EX-99.1

q9bb1 fm9p0jr

10 Aug 23

Report of Foreign Private Issuer

6:03am

6-K

EX-99.1

nf1col5xch

8 Aug 23

Clarion Clinics Begins Accepting Registrations for Psychedelic Treatment Interest as Part of Pre-Screening in Readiness for Opening

6:02am

6-K

woyu367i

8 Aug 23

Clarion Clinics Begins Accepting Registrations for Psychedelic Treatment Interest as Part of Pre-Screening in Readiness for Opening

6:02am

6-K

cghqt4o2fqkyzqcvris

31 Jul 23

Incannex Provides Access to Financial Advisory Firm to Shareholders for Advice Pertaining to Transition from ASX to Nasdaq

7:34pm

6-K

EX-99.1

8uv lmmflj6402gmihbg

31 Jul 23

Incannex Provides Access to Financial Advisory Firm to Shareholders for Advice Pertaining to Transition from ASX to Nasdaq

7:34pm

6-K

dgc6wpgu22qgyu05

27 Jul 23

Incannex Healthcare June 2023 Quarterly Activities Report and Appendix 4C Cash Flow Statement

8:47pm

6-K

EX-99.1

t0j0a2b56wjs60r

27 Jul 23

Incannex Healthcare June 2023 Quarterly Activities Report and Appendix 4C Cash Flow Statement

8:47pm

6-K

k5jmam 2r7s

25 Jul 23

Incannex Completes Positive Pre-IND Meeting with US FDA on IHL-675A for Treatment of Rheumatoid Arthritis

9:42pm

6-K

EX-99.1

chccm0cg7v9h69p3skvn

25 Jul 23

Incannex Completes Positive Pre-IND Meeting with US FDA on IHL-675A for Treatment of Rheumatoid Arthritis

9:42pm

6-K

0i2dh5nm 4pqjt9

20 Jul 23

Incannex Submits IND Application to the US FDA for IHL-42X for Obstructive Sleep Apnoea

9:47pm

6-K

EX-99.1

c40ldy

20 Jul 23

Incannex Submits IND Application to the US FDA for IHL-42X for Obstructive Sleep Apnoea

9:47pm

6-K

310raxtx2fvn iiams5

18 Jul 23

Incannex engages Fortrea to Manage its FDA IND Opening Phase 2/3 Clinical Trial Investigating IHL-42X for Treatment of Obstructive Sleep Apnoea

6:04am

6-K

EX-99.1

qs1d 4bsk

18 Jul 23

Incannex engages Fortrea to Manage its FDA IND Opening Phase 2/3 Clinical Trial Investigating IHL-42X for Treatment of Obstructive Sleep Apnoea

6:04am

6-K

EX-99.1

9sq3lthrhjp4

13 Jul 23

Incannex Receives HREC Approval for Phase 2 Clinical Trial Assessing IHL-675A for use in Treatment of Pain and Function in Rheumatoid Arthritis

6:02am

6-K

bn8v7 wyzq

13 Jul 23

Incannex Receives HREC Approval for Phase 2 Clinical Trial Assessing IHL-675A for use in Treatment of Pain and Function in Rheumatoid Arthritis

6:02am

6-K

6mklrbh5z4s 2gp5

10 Jul 23

Incannex Announces Intention to Redomicile to United States, List all Shares on Nasdaq

8:43am

6-K

EX-99.1

lw1uzw

10 Jul 23

Incannex Announces Intention to Redomicile to United States, List all Shares on Nasdaq

8:43am

6-K

EX-99.1

hsa2ylckdll1n36n60xi

5 Jul 23

Report of Foreign Private Issuer

8:47pm

6-K

o8jr98e

5 Jul 23

Report of Foreign Private Issuer

8:47pm